ALNYLAM PHARMACEUTICALS, INC.
Sign in to add to a watchlist →
lobbying_client · US · canonical: alnylam pharmaceuticals · 3 aliases · 6 outbound · 16 inbound
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-18 · lobbied by John Martin · lda_lobbyist_client
- 2026-05-18 · lobbied by Sophie Khanahmadi · lda_lobbyist_client
- 2026-05-18 · lobbied by Maximilian Walter · lda_lobbyist_client
- 2026-05-18 · lobbied by John Kirkland Twomey · lda_lobbyist_client
- 2026-05-18 · lobbied by Corey Malmgren · lda_lobbyist_client
- 2026-05-18 · lobbied by Jeffrey Carroll · lda_lobbyist_client
- 2026-05-18 · lobbied by Sonia Goh · lda_lobbyist_client
- 2026-05-18 · lobbied by Alanna Temme · lda_lobbyist_client
- 2026-05-18 · lobbied by Jonathon Jones · lda_lobbyist_client
- 2026-05-18 · lobbied by John Michael Gonzalez · lda_lobbyist_client
- 2026-01-01 · lobbied on ORPHAN Cures Act (h.r. 946) · lobbying_bill_mention
- 2026-01-01 · lobbied on Maintaining Investments in New Innovation Act (h.r. 1672) · lobbying_bill_mention
- 2026-01-01 · lobbied for by TIBER CREEK GROUP $60,000 · lda_filing
- 2026-01-01 · lobbied on ORPHAN Cures Act (s.1862) · lobbying_bill_mention
- 2026-01-01 · lobbied for by LMH STRATEGIC SOLUTIONS $50,000 · lda_filing
- 2026-01-01 · lobbied on ORPHAN Cures Act (h.r.946) · lobbying_bill_mention
- 2026-01-01 · lobbied on ORPHAN Cures Act (s. 1862) · lobbying_bill_mention
- 2026-01-01 · lobbied for by CAPITOL COUNSEL LLC $60,000 · lda_filing
- 2026-01-01 · lobbied on Maintaining Investments in New Innovation Act (h.r.1672) · lobbying_bill_mention
- 2025-01-01 · lobbied for by LMH STRATEGIC SOLUTIONS · lda_filing
- 2025-01-01 · lobbied for by CAPITOL COUNSEL LLC · lda_filing
- 2025-01-01 · lobbied for by CAPITOL COUNSEL LLC · lda_filing
Lobbying disclosures — as CLIENT (6)
Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.
| Posted | Filing | Year | Period | Registrant (lobbying firm) | Income | Expenses |
|---|---|---|---|---|---|---|
| 2026-04-17 | 1st Quarter - Report | 2026 | first_quarter | 20744 | $60,000 | — |
| 2026-04-17 | 1st Quarter - Report | 2026 | first_quarter | 401108183 | $50,000 | — |
| 2026-04-16 | 1st Quarter - Report | 2026 | first_quarter | 313715 | $60,000 | — |
| 2025-03-09 | Registration | 2025 | first_quarter | 401108183 | — | — |
| 2025-03-07 | Registration - Amendment | 2025 | first_quarter | 313715 | — | — |
| 2025-03-07 | Registration | 2025 | first_quarter | 313715 | — | — |
Aliases (3)
| source | id | name at source | jurisdiction | confidence | linked by | linked at |
|---|---|---|---|---|---|---|
| lda_client | 54640 | ALNYLAM PHARMACEUTICALS, INC. | US | gold | backfill_0029 | |
| lda_client | 64701 | ALNYLAM PHARMACEUTICALS, INC. | US | gold | backfill_0029 | |
| lda_client | 64726 | ALNYLAM PHARMACEUTICALS, INC. | US | gold | backfill_0029 |
Outbound edges (6)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | HR 1672 — Maintaining Investments in New Innovation Act | — | H.R. 1672 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 946 — ORPHAN Cures Act | — | H.R. 946 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1862 — ORPHAN Cures Act | — | S. 1862 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1672 — Maintaining Investments in New Innovation Act | — | H.R.1672 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 946 — ORPHAN Cures Act | — | H.R.946 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1862 — ORPHAN Cures Act | — | S.1862 | lobbying_bill_mention |
Inbound edges (16)
| date | from | type | amount | source |
|---|---|---|---|---|
| — | John Michael Gonzalez | lobbied_for | — | lda_lobbyist_client |
| — | Jonathon Jones | lobbied_for | — | lda_lobbyist_client |
| — | Alanna Temme | lobbied_for | — | lda_lobbyist_client |
| — | Sonia Goh | lobbied_for | — | lda_lobbyist_client |
| — | Jeffrey Carroll | lobbied_for | — | lda_lobbyist_client |
| — | Corey Malmgren | lobbied_for | — | lda_lobbyist_client |
| — | John Kirkland Twomey | lobbied_for | — | lda_lobbyist_client |
| — | Maximilian Walter | lobbied_for | — | lda_lobbyist_client |
| — | Sophie Khanahmadi | lobbied_for | — | lda_lobbyist_client |
| — | John Martin | lobbied_for | — | lda_lobbyist_client |
| 2025-01-01 | CAPITOL COUNSEL LLC | lobbies_for | — | lda_filing |
| 2025-01-01 | CAPITOL COUNSEL LLC | lobbies_for | — | lda_filing |
| 2025-01-01 | LMH STRATEGIC SOLUTIONS | lobbies_for | — | lda_filing |
| 2026-01-01 | TIBER CREEK GROUP | lobbies_for | $60,000 | lda_filing |
| 2026-01-01 | CAPITOL COUNSEL LLC | lobbies_for | $60,000 | lda_filing |
| 2026-01-01 | LMH STRATEGIC SOLUTIONS | lobbies_for | $50,000 | lda_filing |